‌

US Patent 11572383 Methods of synthesizing substituted purine compounds

Overview Structured Data Issues Contributors

Is a

Current Assignee

Date Filed

September 18, 2020

Date of Patent

February 7, 2023

Patent Applicant

Patent Application Number

17025508

Patent Citations

US Patent 10525074 Combination therapy for treating cancer

US Patent 10112968 Inhibitors of protein methyltransferase DOT1L and methods of use thereof

US Patent 10143704 Methods for treating cancer

US Patent 10400005 Substituted purine compounds

US Patent 10407732 Methods for the detection and treatment of leukemias that are responsive to DOT1L inhibition

US Patent 10968247 Methods of synthesizing substituted purine compounds

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Primary Examiner

Patrick T. Lewis

Find more entities like US Patent 11572383 Methods of synthesizing substituted purine compounds

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.